Information Library
Case Studies - Flexible outsourcing - Get to market faster
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
Syndicated Solutions
June 30, 2010
Astellas needed to rapidly ramp up its sales force by 50% to take advantage of a projected $1 billion opportunity. Quintiles provided a new risk -
Global Flexibility
May 9, 2010
PharmaMar faced a massive logistical challenge. It needed to quickly mobilize an effective sales force covering a market that spans several different national legislations and more than 20 official languages. With the help of Quintiles, on-time recruitment against aggressive timelines made it possible to top 2007 sales goals in the first year. -
Blockbuster Co-Promotion
May 9, 2010
A pharma company targeted seven countries for quickly promoting its new compound. Read how, in just four months, Quintiles recruited, trained and implemented highly effective field sales teams in all seven new countries. -
Agile Outsourcing
May 9, 2010
Imagine the challenge — a UK-based biotech company gains EMA (formerly known as EMEA) approval for a new compound, with no mainland European sales infrastructure -
Bridging Cultures
May 9, 2010
In 2008, the next stage in Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise. -
Collaborative Promotion
May 9, 2010
A woundcare company was having difficulty reaching the UK’s massive number of district nurses — all widespread in geography and without set offices or schedules. -
How to Keep All Your Licenses in Compliance
March 25, 2009
Our customer had a series of pharmaceutical and biological products that had been on the market in various countries for 10 years or more. They made a number of manufacturing improvements, and they needed to update their myriad licenses. -
Maneuvering a Drifting Project Back on Course
March 25, 2009
The NDA had been drifting within the FDA for years, and now it was subject to intense scrutiny by two agency reviewers.
Page 1 of 1 (8 results)